Mirador Capital Partners LP - 10X GENOMICS INC ownership

10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 254 filers reported holding 10X GENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.

Quarter-by-quarter ownership
Mirador Capital Partners LP ownership history of 10X GENOMICS INC
ValueSharesWeighting
Q3 2023$1,128,765
-36.5%
27,364
-14.1%
0.26%
-39.1%
Q2 2023$1,778,169
-3.6%
31,844
-3.6%
0.42%
-3.4%
Q1 2023$1,843,804
+90.4%
33,049
+24.4%
0.44%
+90.8%
Q4 2022$968,247
+20.3%
26,571
-6.0%
0.23%
+18.0%
Q3 2022$805,000
+13.4%
28,281
+80.2%
0.19%
+15.5%
Q2 2022$710,000
-57.5%
15,694
-28.5%
0.17%
-50.3%
Q1 2022$1,670,000
-47.8%
21,947
+2.2%
0.34%
-49.9%
Q4 2021$3,200,000
+9.2%
21,483
+6.7%
0.67%
+1.4%
Q3 2021$2,931,000
-4.1%
20,130
+28.9%
0.66%
-3.9%
Q2 2021$3,057,000
+19.0%
15,611
+10.0%
0.69%
+5.0%
Q1 2021$2,568,000
+26.1%
14,186
-1.3%
0.66%
+17.9%
Q4 2020$2,036,000
+21.5%
14,377
+7.0%
0.56%
+7.1%
Q3 2020$1,676,000
+46.0%
13,439
+4.6%
0.52%
+21.7%
Q2 2020$1,148,000
+18.6%
12,851
+4.5%
0.43%
+6.2%
Q1 2020$968,000
+195.1%
12,294
+185.9%
0.40%
+206.1%
Q4 2019$328,0004,3000.13%
Other shareholders
10X GENOMICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Venrock Management VI, LLC 8,185,565$952,538,00099.56%
Foresite Capital Management I, LLC 2,750,000$342,870,00096.54%
Foresite Capital Management II, LLC 3,503,528$436,820,00095.05%
12 West Capital Management LP 1,922,000$239,635,00011.66%
FINANCIAL CONSULATE, INC 163,366$20,368,0009.67%
JS Capital Management LLC 606,400$75,606,0003.91%
Asymmetry Capital Management, L.P. 43,512$5,425,0003.49%
Pinz Capital Management, LP 55,400$6,907,0002.52%
HAMILTON LANE ADVISORS LLC 37,087$4,624,0002.24%
RTW INVESTMENTS, LP 660,933$82,405,0001.98%
View complete list of 10X GENOMICS INC shareholders